$CRVS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Corvus Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Corvus Pharmaceuticals, Inc.. Get notifications about new insider transactions in Corvus Pharmaceuticals, Inc. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 16 2021	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Option Exercise	A	2.74	15,000	41,100	15,000
May 05 2021	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	2.80	35,714	99,999	35,714	0 to 35.7 K
Feb 19 2021	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	3.50	1,285,714	4,499,999	8,053,298	6.8 M to 8.1 M (+19.00 %)
Feb 19 2021	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.50	1,285,714	4,499,999	8,053,298	6.8 M to 8.1 M (+19.00 %)
Dec 17 2020	CRVS	Corvus Pharmaceuti ...	Jones William Benton	See Remarks	Option Exercise	A	4.01	160,000	641,600	160,000
Dec 17 2020	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Option Exercise	A	4.01	160,000	641,600	160,000
Dec 17 2020	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Option Exercise	A	4.01	320,000	1,283,200	320,000
Dec 17 2020	CRVS	Corvus Pharmaceuti ...	Mobasher Mehrdad	SVP, Chief Medical ...	Option Exercise	A	4.01	85,000	340,850	85,000
Sep 15 2020	CRVS	Corvus Pharmaceuti ...	Mitchell Edith P.	Director	Option Exercise	A	3.95	30,000	118,500	30,000
Jul 09 2020	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Sell	S	5.37	741,440	3,985,166	1,389,498	2.1 M to 1.4 M (-34.79 %)
Jul 09 2020	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Sell	S	5.25	796,622	4,183,381	2,130,938	2.9 M to 2.1 M (-27.21 %)
Jun 15 2020	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Option Exercise	A	3.27	15,000	49,050	15,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Morrison Scott W	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Krognes Steve E.	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Grais Linda S	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	CLARK IAN T	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Grais Linda S	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	CLARK IAN T	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Krognes Steve E.	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Morrison Scott W	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Option Exercise	A	2.00	15,000	30,000	15,000
Dec 16 2019	CRVS	Corvus Pharmaceuti ...	Verner Erik J.	VP, Chemistry Resea ...	Option Exercise	A	3.54	50,000	177,000	50,000
Dec 16 2019	CRVS	Corvus Pharmaceuti ...	Mobasher Mehrdad	VP, Chief Medical O ...	Option Exercise	A	3.54	50,000	177,000	50,000
Dec 16 2019	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Option Exercise	A	3.54	160,000	566,400	160,000
Dec 16 2019	CRVS	Corvus Pharmaceuti ...	Jones William Benton	See Remarks	Option Exercise	A	3.54	160,000	566,400	160,000
Dec 16 2019	CRVS	Corvus Pharmaceuti ...	Hunt Daniel W.	SVP, Chief Business ...	Option Exercise	A	3.54	75,000	265,500	75,000
Dec 16 2019	CRVS	Corvus Pharmaceuti ...	Buggy Joseph J	EVP, Discovery Rese ...	Option Exercise	A	3.54	40,000	141,600	40,000
Aug 08 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.51	142,656	500,723	6,767,584	6.6 M to 6.8 M (+2.15 %)
Aug 08 2019	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	3.51	142,656	500,723	6,767,584	6.6 M to 6.8 M (+2.15 %)
Aug 08 2019	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.54	2,500	8,850	1,163,507	1.2 M to 1.2 M (+0.22 %)
Aug 08 2019	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.58	5,000	17,875	1,161,007	1.2 M to 1.2 M (+0.43 %)
Jul 25 2019	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Sell	S	4.00	1,400,000	5,600,000	2,927,560	4.3 M to 2.9 M (-32.35 %)
Jul 25 2019	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Sell	S	5.01	53,240	266,711	4,327,560	4.4 M to 4.3 M (-1.22 %)
Jul 25 2019	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Sell	S	5.32	39,716	211,134	4,380,800	4.4 M to 4.4 M (-0.90 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.91	59,243	231,640	6,624,928	6.6 M to 6.6 M (+0.90 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.72	565,178	2,102,462	6,565,685	6 M to 6.6 M (+9.42 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.34	32,923	109,963	6,000,507	6 M to 6 M (+0.55 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	3.91	59,243	231,640	6,624,928	6.6 M to 6.6 M (+0.90 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	3.72	565,178	2,102,462	6,565,685	6 M to 6.6 M (+9.42 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	3.34	32,923	109,963	6,000,507	6 M to 6 M (+0.55 %)
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Krognes Steve E.	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Morrison Scott W	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Grais Linda S	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	CLARK IAN T	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 17 2019	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.40	11,657	39,666	1,156,007	1.1 M to 1.2 M (+1.02 %)
Jun 17 2019	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.52	343	1,207	1,144,350	1.1 M to 1.1 M (+0.03 %)
Jun 11 2019	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.67	6,000	22,020	1,144,007	1.1 M to 1.1 M (+0.53 %)
Jun 11 2019	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.37	9,212	31,019	1,138,007	1.1 M to 1.1 M (+0.82 %)
Jun 10 2019	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Buy	P	3.38	10,000	33,800	50,200	40.2 K to 50.2 K (+24.88 %)
Jun 10 2019	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Buy	P	3.56	15,500	55,180	40,200	24.7 K to 40.2 K (+62.75 %)
Jan 30 2019	CRVS	Corvus Pharmaceuti ...	Grais Linda S	Director	Option Exercise	A	3.88	30,000	116,400	30,000
Jan 30 2019	CRVS	Corvus Pharmaceuti ...	Mobasher Mehrdad	Chief Medical Offic ...	Option Exercise	A	3.88	210,000	814,800	210,000
Dec 31 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	3.29	20,000	65,884	1,128,795	1.1 M to 1.1 M (+1.80 %)
Dec 27 2018	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Buy	P	4.15	24,700	102,409	24,700	0 to 24.7 K
Dec 26 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	4.39	5,000	21,950	1,108,795	1.1 M to 1.1 M (+0.45 %)
Dec 26 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	4.40	5,000	22,000	1,103,795	1.1 M to 1.1 M (+0.46 %)
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	Jones William Benton	See Remarks	Option Exercise	A	5.94	100,000	594,000	100,000
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Option Exercise	A	5.94	250,000	1,485,000	250,000
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Gift	G	0.00	10,000	0	1,098,795	1.1 M to 1.1 M (-0.90 %)
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Gift	G	0.00	10,000	0	1,108,795	1.1 M to 1.1 M (-0.89 %)
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	Buggy Joseph J	EVP Discovery Resea ...	Option Exercise	A	5.94	100,000	594,000	100,000
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Option Exercise	A	5.94	100,000	594,000	100,000
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	Hunt Daniel W.	SVP, Chief Business ...	Option Exercise	A	5.94	50,000	297,000	50,000
Dec 14 2018	CRVS	Corvus Pharmaceuti ...	Verner Erik J.	V.P., Chemistry Res ...	Option Exercise	A	5.94	50,000	297,000	50,000
Dec 10 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	5.99	5,000	29,934	1,118,795	1.1 M to 1.1 M (+0.45 %)
Dec 06 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	5.95	1,502	8,937	1,113,795	1.1 M to 1.1 M (+0.14 %)
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Option Exercise	A	12.50	15,000	187,500	15,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	Morrison Scott W	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	CLARK IAN T	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	Krognes Steve E.	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Mar 14 2018	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	8.50	588,235	4,999,998	5,967,584	5.4 M to 6 M (+10.94 %)
Mar 14 2018	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	8.50	588,235	4,999,998	5,967,584	5.4 M to 6 M (+10.94 %)
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Buy	P	8.50	1,176,470	9,999,995	4,420,516	3.2 M to 4.4 M (+36.27 %)
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Buy	P	8.50	126,806	1,077,851	126,806	0 to 126.8 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Buy	P	8.50	87,668	745,178	87,668	0 to 87.7 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Buy	P	8.50	67,769	576,037	67,769	0 to 67.8 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Buy	P	8.50	236,128	2,007,088	236,128	0 to 236.1 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Buy	P	8.50	69,864	593,844	69,864	0 to 69.9 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Buy	P	8.50	126,806	1,077,851	126,806	0 to 126.8 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Buy	P	8.50	87,668	745,178	87,668	0 to 87.7 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Buy	P	8.50	67,769	576,037	67,769	0 to 67.8 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Buy	P	8.50	236,128	2,007,088	236,128	0 to 236.1 K
Mar 13 2018	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Buy	P	8.50	69,864	593,844	69,864	0 to 69.9 K
Mar 12 2018	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	8.50	100,000	850,000	1,112,293	1 M to 1.1 M (+9.88 %)
Jan 23 2018	CRVS	Corvus Pharmaceuti ...	Buggy Joseph J	EVP Discovery Resea ...	Option Exercise	A	9.94	100,000	994,000	100,000
Dec 15 2017	CRVS	Corvus Pharmaceuti ...	Verner Erik J.	V.P., Chemistry Res ...	Option Exercise	A	10.60	25,000	265,000	25,000
Dec 15 2017	CRVS	Corvus Pharmaceuti ...	Jones William Benton	See Remarks	Option Exercise	A	10.60	40,000	424,000	40,000
Dec 15 2017	CRVS	Corvus Pharmaceuti ...	Hunt Daniel W.	SVP, Chief Business ...	Option Exercise	A	10.60	200,000	2,120,000	200,000
Dec 15 2017	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Option Exercise	A	10.60	40,000	424,000	40,000
Dec 15 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Option Exercise	A	10.60	125,000	1,325,000	125,000
Nov 22 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	10.79	10,000	107,850	1,012,293	1 M to 1 M (+1.00 %)
Jun 27 2017	CRVS	Corvus Pharmaceuti ...	Novo Holdings A/S	10% Owner	Buy	P	10.95	20,000	219,000	3,244,046	3.2 M to 3.2 M (+0.62 %)
Jun 13 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	10.14	2,500	25,350	1,002,293	999.8 K to 1 M (+0.25 %)
Jun 13 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	9.75	2,500	24,375	999,793	997.3 K to 999.8 K (+0.25 %)
Jun 13 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	9.82	11,216	110,185	997,293	986.1 K to 997.3 K (+1.14 %)
Jun 13 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	9.89	3,784	37,424	986,077	982.3 K to 986.1 K (+0.39 %)
Jun 13 2017	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	9.95	5,000	49,750	982,293	977.3 K to 982.3 K (+0.51 %)
Jun 09 2017	CRVS	Corvus Pharmaceuti ...	Gould Terry P	Director	Option Exercise	A	9.70	15,000	145,500	15,000
Jun 09 2017	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	9.70	15,000	145,500	15,000
Jun 09 2017	CRVS	Corvus Pharmaceuti ...	ADAMS STREET PARTNERS LLC	10% Owner	Option Exercise	A	9.70	15,000	145,500	15,000
Jan 04 2017	CRVS	Corvus Pharmaceuti ...	CLARK IAN T	Director	Option Exercise	A	14.43	30,000	432,900	30,000
Dec 08 2016	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Option Exercise	A	16.37	160,000	2,619,200	160,000
Dec 08 2016	CRVS	Corvus Pharmaceuti ...	Verner Erik J.	V.P., Chemistry Res ...	Option Exercise	A	16.37	25,000	409,250	25,000
Dec 08 2016	CRVS	Corvus Pharmaceuti ...	Jones William Benton	VP Pharmaceutical D ...	Option Exercise	A	16.37	25,000	409,250	25,000
Dec 08 2016	CRVS	Corvus Pharmaceuti ...	LEA LEIV	Chief Financial Off ...	Option Exercise	A	16.37	25,000	409,250	25,000
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.99	900	11,691	5,379,349	5.4 M to 5.4 M (+0.02 %)
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.92	100	1,292	5,378,449	5.4 M to 5.4 M (0.00 %)
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.99	900	11,691	5,379,349	5.4 M to 5.4 M (+0.02 %)
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.92	100	1,292	5,378,449	5.4 M to 5.4 M (0.00 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.87	26,083	335,688	5,378,349	5.4 M to 5.4 M (+0.49 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.48	12,300	153,504	5,352,266	5.3 M to 5.4 M (+0.23 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.87	26,083	335,688	5,378,349	5.4 M to 5.4 M (+0.49 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.48	12,300	153,504	5,352,266	5.3 M to 5.4 M (+0.23 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.04	5,000	60,200	5,339,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	11.94	5,000	59,700	5,334,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.71	10,000	127,100	5,329,966	5.3 M to 5.3 M (+0.19 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.04	5,000	60,200	5,339,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	11.94	5,000	59,700	5,334,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.71	10,000	127,100	5,329,966	5.3 M to 5.3 M (+0.19 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.98	20,000	259,600	5,319,966	5.3 M to 5.3 M (+0.38 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.95	30,000	388,500	5,299,966	5.3 M to 5.3 M (+0.57 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.98	20,000	259,600	5,319,966	5.3 M to 5.3 M (+0.38 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.95	30,000	388,500	5,299,966	5.3 M to 5.3 M (+0.57 %)
Jun 10 2016	CRVS	Corvus Pharmaceuti ...	Coloma Jason V	SVP, Chief Business ...	Option Exercise	A	13.34	200,000	2,668,000	200,000
May 24 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	13.09	4,716	61,732	5,269,966	5.3 M to 5.3 M (+0.09 %)
May 24 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	13.09	4,716	61,732	5,269,966	5.3 M to 5.3 M (+0.09 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.75	61	778	5,265,250	5.3 M to 5.3 M (0.00 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	12.11	2,539	30,747	5,265,189	5.3 M to 5.3 M (+0.05 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Buy	P	11.55	4,200	48,510	5,262,650	5.3 M to 5.3 M (+0.08 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.75	61	778	5,265,250	5.3 M to 5.3 M (0.00 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.11	2,539	30,747	5,265,189	5.3 M to 5.3 M (+0.05 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	11.55	4,200	48,510	5,262,650	5.3 M to 5.3 M (+0.08 %)
May 16 2016	CRVS	Corvus Pharmaceuti ...	Novo A/S	10% Owner	Buy	P	10.00	70,000	700,000	3,224,046	3.2 M to 3.2 M (+2.22 %)
May 16 2016	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	9.94	300	2,981	1,077,293	1.1 M to 1.1 M (+0.03 %)
May 16 2016	CRVS	Corvus Pharmaceuti ...	MILLER RICHARD A MD	President and CEO	Buy	P	10.00	30,000	300,000	1,076,993	1 M to 1.1 M (+2.87 %)
Mar 30 2016	CRVS	Corvus Pharmaceuti ...	Novo A/S	10% Owner	Option Exercise	C	0.00	356,888	0	0
Mar 30 2016	CRVS	Corvus Pharmaceuti ...	Novo A/S	10% Owner	Option Exercise	C	0.00	2,130,492	0	0
Mar 30 2016	CRVS	Corvus Pharmaceuti ...	Novo A/S	10% Owner	Buy	P	15.00	666,666	9,999,990	3,154,046	2.5 M to 3.2 M (+26.80 %)
Mar 30 2016	CRVS	Corvus Pharmaceuti ...	Novo A/S	10% Owner	Buy	C	0.00	356,888	0	2,487,380	2.1 M to 2.5 M (+16.75 %)
Mar 30 2016	CRVS	Corvus Pharmaceuti ...	Novo A/S	10% Owner	Buy	C	0.00	2,130,492	0	2,130,492	0 to 2.1 M
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	ORBIMED ADVISORS LLC	Director	Option Exercise	C	0.00	713,776	0	0

Page: 1 2 next >